| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-26 05:59:33 UTC |
|---|
| Update Date | 2016-11-09 01:21:21 UTC |
|---|
| Accession Number | CHEM035690 |
|---|
| Identification |
|---|
| Common Name | 4-Chloromethandienone |
|---|
| Class | Small Molecule |
|---|
| Description | |
|---|
| Contaminant Sources | |
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Chloro-methandienone | MeSH | | CDMT | MeSH | | D-4-Chloro-17 beta-hydroxy-3-oxo-17 alpha-methylandrosta-1,4-diene | MeSH | | Oral turinabol | MeSH | | Turinabol-oral | MeSH | | Dehydrochlormethyltestosterone | MeSH | | (17b)-4-chloro-17-Hydroxy-17-methyl-androsta-1,4-dien-3-one | HMDB | | 1-dehydro-4-chloro-17-Methyltestosterone | HMDB | | 1-dehydro-4-chloro-17a-Methyltestosterone | HMDB | | 4-chloro-1,2-dehydro-17a-Methyltestosterone | HMDB | | 4-chloro-1-dehydro-17-Methyltestosterone | HMDB | | 4-chloro-1-Dehydromethyltestosterone | HMDB | | 4-chloro-17a-Methyl-17b-hydroxyandrosta-1,4-dien-3-one | HMDB | | 4-chloro-17b-Hydroxy-17-methyl-androsta-1,4-dien-3-one | HMDB | | 4-chloro-17b-Hydroxy-17a-methyl-5a-androsta-1,4-dien-3-one | HMDB | | 4-Chlorodehydromethyltestosterone | HMDB | | 4-Chlorodianabol | HMDB | | Oral-turinabol | HMDB |
|
|---|
| Chemical Formula | C20H27ClO2 |
|---|
| Average Molecular Mass | 334.880 g/mol |
|---|
| Monoisotopic Mass | 334.170 g/mol |
|---|
| CAS Registry Number | 2446-23-3 |
|---|
| IUPAC Name | (1S,2R,10R,11S,14S,15S)-6-chloro-14-hydroxy-2,14,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-3,6-dien-5-one |
|---|
| Traditional Name | oral turinabol |
|---|
| SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=C(Cl)C(=O)C=C[C@]12C |
|---|
| InChI Identifier | InChI=1S/C20H27ClO2/c1-18-9-8-16(22)17(21)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h8-9,12-14,23H,4-7,10-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1 |
|---|
| InChI Key | AGUNEISBPXQOPA-XMUHMHRVSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 3-oxo-delta-1,4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- 4-halo-steroid
- Halo-steroid
- Oxosteroid
- Hydroxysteroid
- Delta-1,4-steroid
- Alpha-haloketone
- Alpha-chloroketone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Chloroalkene
- Haloalkene
- Vinyl halide
- Vinyl chloride
- Alcohol
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organooxygen compound
- Organochloride
- Organohalogen compound
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-06di-2359000000-29ca0d52c8fd70fc30d5 | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-004l-5249000000-9650931bf7b8f174feae | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-014r-0009000000-4d48d5496c111810a053 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-014r-0298000000-37b2f0f935b6a78a8bb2 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0f7c-4593000000-492a05f7e32939505e60 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0009000000-80bda444bab1f625c66a | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001i-0009000000-17287ea8d4e89a4ee477 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-017j-0094000000-d1ada8f9f78231dd96f7 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-0009000000-9ddc118eccb9db975822 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001i-9004000000-9a783b35f47e53ab4eb4 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-001i-9072000000-7ac5075eb9109bfda145 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00kr-0019000000-c2e40146619d50f32d69 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-1973000000-ea8ac005cf57c5cd7c8b | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a6r-2590000000-1f06ae27f07b88dfa774 | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB0004634 |
|---|
| FooDB ID | FDB023389 |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Chlorodehydromethyltestosterone |
|---|
| Chemspider ID | 88972 |
|---|
| ChEBI ID | Not Available |
|---|
| PubChem Compound ID | 98521 |
|---|
| Kegg Compound ID | Not Available |
|---|
| YMDB ID | Not Available |
|---|
| ECMDB ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | | 1. Du, Hongwu; Lu, Yuan; Yang, Weiping; Wu, Moutian; Wang, Jun; Zhao, Shan; Pan, Mangeng; Cheng, Jing. Preparation of Steroid Antibodies and Parallel Detection of Multianabolic Steroid Abuse with Conjugated Hapten Microarray. Analytical Chemistry (2004), 76(20), 6166-6171. | | 2. Du, Hongwu; Lu, Yuan; Yang, Weiping; Wu, Moutian; Wang, Jun; Zhao, Shan; Pan, Mangeng; Cheng, Jing. Preparation of Steroid Antibodies and Parallel Detection of Multianabolic Steroid Abuse with Conjugated Hapten Microarray. Analytical Chemistry (2004), 76(20), 6166-6171. | | 3. Froehner M, Fischer R, Leike S, Hakenberg OW, Noack B, Wirth MP: Intratesticular leiomyosarcoma in a young man after high dose doping with Oral-Turinabol: a case report. Cancer. 1999 Oct 15;86(8):1571-5. |
|
|---|